CXCL11



CXCL11

F1FF1L2LL2M3MM3F4FF4K5KK5Q6QQ6G7GG7R8RR8C9CC9L10LL10C11CC11I12II12G13GG13P14PP14G15GG15M16MM16K17KK17A18AA18V19VV19K20KK20M21MM21A22AA22E23EE23I24II24E25EE25K26KK26A27AA27S28SS28V29VV29I30II30Y31YY31P32PP32S33SS33N34NN34G35GG35C36CC36D37DD37K38KK38V39VV39E40EE40V41VV41I42II42V43VV43T44TT44M45MM45K46KK46A47AA47... and 32 more residue(s)...... and 32 more residue(s)

SMILES None
InChIKey None
Sequence FLMFKQGRCLCIGPGMKAVKMAEIEKASVIYPSNGCDKVEVIVTMKAHKRQRCLDPRSKQARLIMQAIEKKNFLRRQNM

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



No bioactivity data available.

CXCL11

F1FF1L2LL2M3MM3F4FF4K5KK5Q6QQ6G7GG7R8RR8C9CC9L10LL10C11CC11I12II12G13GG13P14PP14G15GG15M16MM16K17KK17A18AA18V19VV19K20KK20M21MM21A22AA22E23EE23I24II24E25EE25K26KK26A27AA27S28SS28V29VV29I30II30Y31YY31P32PP32S33SS33N34NN34G35GG35C36CC36D37DD37K38KK38V39VV39E40EE40V41VV41I42II42V43VV43T44TT44M45MM45K46KK46A47AA47... and 32 more residue(s)...... and 32 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.